MET expression in sporadic renal cell carcinomas

Journal of Korean Medical Science

Volumn 21, Issue 4, 2006, Pages 672-677

  Jong, Sun Choi ^b   Kim, Mi Kyung ^a   Jin, Won Seo ^a   Choi, Yoon La ^a   Dong, Hoon Kim ^a   Yi, Kyeong Chun ^b   Young, Hyeh Ko ^a,b  

^a Samsung Medical Center   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Carcinoma, renal cell; Immunohistochemistry; Kidney; Kidney Neoplasms; Proto oncogene proteins c met

Indexed keywords

EID: 33746917945     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2006.21.4.672     Document Type: Article

References (28)

1. Gonzatti-Haces M, Seth A, Park M, Copeland T, Oroszlan S, Vande Woude GF. Characterization of the TPR-MET oncogene p65 and the MET protooncogene p140 protein-tyrosine kinases. Proc Natl Acad Sci USA 1988; 85: 21-5.
2. Rubin JS, Chan AM, Bottaro DP, Burgess WH, Taylor WG, Cech AC, Hirschfield DW, Wong J, Miki T, Finch PW, Aaronson SA. A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. Proc Natl Acad Sci USA 1991; 88: 415-9.
3. Stoker M, Gherardi E, Perryman M, Gray J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 1987; 327: 239-42.
4. Tsarfaty I, Resau JH, Rulong S, Keydar I, Faletto DL, Vande Woude GF. The met proto-oncogene receptor and lumen formation. Science 1992; 257: 1258-61.
5. Woolf AS, Kolatsi-Joannou M, Hardman P, Andermarcher E, Moorby C, Fine LG, Jat PS, Noble MD, Gherardi E. Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros. J Cell Biol 1995; 128: 171-84.
6. Sonnenberg E, Meyer D, Weidner KM, Birchmeier C. Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J Cell Biol 1993; 123: 223-35.
7. Horie S, Aruga S, Kawamata H, Okui N, Kakizoe T, Kitamura T. Biological role of HGF/MET pathway in renal cell carcinoma. J Urol 1999; 161: 990-7.
8. Schmidt L, Duh FM, Chen F, Kishida T, Glenn G, Choyke P, Scherer SW, Zhuang Z, Lubensky I, Dean M, Allikmets R, Chidambaram A, Bergerheim UR, Feltis JT, Casadevall C, Zamarron A, Bernues M, Richard S, Lips CJ, Walther MM, Tsui LC, Geil L, Orcutt ML, Stackhouse T, Lipan J, Slife L, Brauch H, Decker J, Niehans G, Hughson MD, Moch H, Storkel S, Lerman MI, Linehan WM, Zbar B. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 1997; 16: 68-73.
9. Schmidt L, Junker K, Nakaigawa N, Kinjerski T, Weirich G, Miller M, Lubensky I, Neumann HP, Brauch H, Decker J, Vocke C, Brown JA, Jenkins R, Richard S, Bergerheim U, Gerrard B, Dean M, Linehan WM, Zbar B. Novel mutations of the MET proto-oncogene in papillary renal carcinomas. Oncogene 1999; 18: 2343-50.
10. Fischer J, Palmedo G, von Knobloch R, Bugert P, Prayer-Galetti T, Pagano F, Kovacs G. Duplication and overexpression of the mutant allele of the MET proto-oncogene in multiple hereditary papillary renal tumours. Oncogene 1998; 17: 733-9.
11. Sweeney P, EL-Naggar AK, Lin S, Pisters LL. Biological significance of c-met overexpression in papillary renal cell carcinoma. J Urol 2002; 168: 51-5.
12. The World Health Organization Working Group. Tumours of the kidney. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA, editors, World Health Organization Classification. Pathology and Genetics of Tumours of the urinary system and male genital organs. Lyon: IARC Press 2004: 9-87.
13. Delahunt B, Eble JN. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol 1997; 10: 537-44.
14. Thoenes W, Störkel S, Rumpelt HJ, Moll R, Baum HP, Werner S. Chromophobe cell renal carcinoma and its variants-a report on 32 cases. J Pathol 1988; 155: 277-87.
15. American Joint Committee on Cancer. Genitourinary Sites. In: Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M, editors, AJCC Cancer staging manual. 6th ed. Chicago: Springer 2002: 301-46.
16. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982; 6: 655-63.
17. Inoue K, Karashima T, Chikazawa M, Iiyama T, Yoshikawa C, Furihata M, Ohtsuki Y, Shuin T. Overexpression of c-met proto-oncogene associated with chromophilic renal cell carcinoma with papillary growth. Virchows Arch 1998; 433: 511-5.
18. Pisters LL, el-Naggar AK, Luo W, Malpica A, Lin SH. C-met proto-oncogene expression in benign and malignant human renal tissues. J Urol 1997; 158: 724-8.
19. Natali PG, Prat M, Nicotra MR, Bigotti A, Olivero M, Comoglio PM, Di Renzo MF. Overexpression of the met/HGF receptor in renal cell carcinomas. Int J Cancer 1996; 69: 212-7.
20. Kovacs G. Molecular cytogenetics of renal cell tumors. Adv Cancer Res 1993; 62: 89-124.
21. Glukhova L, Lavialle C, Fauvet D, Chudoba I, Danglot G, Angevin E, Bernheim A, Goguel AF. Mapping of the 7q31 subregion common to the small chromosome 7 derivatives from two sporadic papillary renal cell carcinomas: Increased copy number and overexpression of the MET protooncogne. Oncogene 2000; 19: 754-61.
22. Jeffers M, Schmidt L, Nakaigawa N, Webb CP, Weirich G, Kishida T, Zbar B, Vande Woude GF. Activating mutations for the met tyrosine kinase receptor in human cancer. Proc Natl Acad Sci USA 1997; 94: 11445-50.
23. Lubensky IA, Schmidt L, Zhuang Z, Weirich G, Pack S, Zambrano N, Walther MM, Choyke P, Linehan WM, Zbar B. Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype. Am J Pathol 1999; 155: 517-26.
24. Polascik TJ, Cairns P, Epstein JI, Fuzesi L, Ro JY, Marshall FF, Sidransky D, Schoenberg M. Distal nephron renal tumors: microsatellite allelotype. Cancer Res 1996; 56: 1892-5.
25. Störkel S, Steart PV, Drenckhahn D, Thoenes W. The human chromophobe cell renal carcinoma: its probable relation to intercalated cells of the collecting duct. Virchows Arch B Cell Pathol Incl Mol Pathol 1989; 56: 237-45.
26. Morra MN, Das S. Renal oncocytoma: a review of histogenesis, histopathology, diagnosis, and treatment. J Urol 1993; 150: 295-302.
27. Li B, Kanamaru H, Noriki S, Fukuda M, Okada K. Differential expression of hepatocyte growth factor in papillary and nodular tumors of the bladder. Int J Urol 1998; 5: 436-40.
28. Tamatani T, Hattori K, Iyer A, Tamatani K, Oyasu R. Hepatocyte growth factor is an invasion/migration factor of rat urothelial carcinoma cells in vitro. Carcinogenesis 1999; 20: 957-62.